Mark Schoenberg
Tracked across 1 events · 6 articles · First seen Jun 14, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Mark Schoenberg, the Chief Medical Officer of UroGen Pharma Ltd., sold shares of the company's common stock in multiple transactions, reducing his direct holdings but still maintaining a significant ownership position. These sales are described as routine liquidity management.
Jun 14, 2026 · 6 articles
90
Mark Schoenberg sold sharesUroGen Pharma CMO Sells Stock
ERGEN INTELLIGENCE
Track Mark Schoenberg live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard